Firm Uses Artificial Intelligence In Drug Development
It’s called BPM 31510 and it is one of many cancer drugs being developed around the country. But it’s also different.
BPM 31510 may be the first drug candidate that was developed by artificial intelligence, instead of scientists running experiments based on a hypothesis.
From the Here & Now Contributors Network, WBUR’s Curt Nickisch reports.
Copyright 2021 NPR. To see more, visit https://www.npr.org.